CXCL13 and myeloid sarcoma: In addition, a significant reduction in CXCL13 levels, a chemokine involved in leukocyte cell trafficking, has recently been found in cerebrospinal fluid from MS patients under treatment with fingolimod supporting a modulatory role of this drug in the cell migration25.